Home > Boards > US Listed > Biotechs > Global Blood Therapeutics (GBT)

Opinion: Biotech stocks are producing outsized gains —

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Timetravelerdos Member Profile
 
Followed By 61
Posts 9,344
Boards Moderated 0
Alias Born 01/10/14
160x600 placeholder
GBT Supports the ASH Research Collaborative's Data Hub Sickle Cell Disease Program PR Newswire (US) - 12/2/2021 8:00:00 AM
GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program GlobeNewswire Inc. - 12/2/2021 8:00:00 AM
GBT Announces Participation at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/24/2021 8:00:00 AM
GBT Announces Participation in Upcoming Investor Conferences GlobeNewswire Inc. - 11/12/2021 8:00:00 AM
GBT Announces New Employment Inducement Grants GlobeNewswire Inc. - 11/8/2021 8:00:00 AM
Merck & Co, Moderna, BioNTech among premarket losers' pack Seeking Alpha - 11/5/2021 8:58:25 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2021 4:49:13 PM
Global Blood Therapeutics EPS misses by $0.02, misses on revenue Seeking Alpha - 11/4/2021 4:27:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2021 4:11:46 PM
GBT Reports Third Quarter 2021 Financial Results GlobeNewswire Inc. - 11/4/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2021 9:06:59 AM
GBT Announces Six Data Presentations on Sickle Cell Disease at Upcoming 63rd American Society of Hematology (ASH) Annual Meeting & Exposition GlobeNewswire Inc. - 11/4/2021 9:05:00 AM
Global Blood Therapeutics Q3 2021 Earnings Preview Seeking Alpha - 11/3/2021 5:35:37 PM
GBT Wins Prestigious Prix Galien USA Award for Oxbryta® (voxelotor) GlobeNewswire Inc. - 11/1/2021 8:00:00 AM
GBT to Announce Third Quarter 2021 Financial Results on Thursday, November 4 GlobeNewswire Inc. - 10/28/2021 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 10/12/2021 12:48:01 PM
Investing in These 2 Stocks Could Double Your Money, Say Analysts TipRanks - 10/7/2021 10:11:20 PM
GBT Announces New Employment Inducement Grants GlobeNewswire Inc. - 10/7/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2021 4:06:01 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/24/2021 7:01:23 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/24/2021 7:01:03 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/24/2021 7:01:02 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/24/2021 7:01:01 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 9/24/2021 7:00:51 PM
GBT Announces Participation at the Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 8:00:00 AM
Timetravelerdos   Wednesday, 12/11/19 12:51:50 PM
Re: None
Post # of 37 
Opinion: Biotech stocks are producing outsized gains — here’s how to get your share
Published: Dec 10, 2019 3:02 p.m. ET

New developments in clinical trials and drug approvals have become commonplace. And buyouts of biotech stocks at high premiums are increasing.

Here is how to get your share of the outsized gains that are being generated. Let’s explore the issue with the help of two charts.

Please click here for an annotated chart of Global Blood Therapeutics GBT, +1.25%.

Please click here for an annotated chart of the buyout of Tesaro by GlaxoSmithKline GSK, +0.15%. The acquisition was completed in January. For the sake of transparency, this chart was previously published.


https://www.marketwatch.com/story/biotech-stocks-are-producing-outsized-gains-heres-how-to-get-your-share-2019-12-09?siteid=yhoof2&yptr=yahoo

Statements made are only my opinion. Do your own DD in order to make your Investment decisions.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences